Trump Promotes Hemp Derived CBD for Senior Health Care in Shared Video

President Trump’s Push for Medicare Coverage of CBD Marks a Turning Point in Senior Health Policy

On September 28, 2025, President Donald Trump amplified the national conversation about medical cannabis reform by sharing a video from the Commonwealth Project on Truth Social. The video advocates for Medicare coverage of hemp-derived CBD and calls for the full integration of medical cannabis into the U.S. health care system for seniors aged 65 and older.

While not the full cannabis rescheduling announcement that many reform advocates have been anticipating, Trump’s endorsement of CBD use among seniors signals a potential shift in federal health care priorities. By supporting CBD coverage through Medicare, the initiative could address chronic pain, inflammation, and other age-related conditions while simultaneously reducing reliance on addictive pharmaceuticals.

The Commonwealth Project’s Message: CBD as a Safer Alternative for Seniors in Pain Management

The video Trump shared was produced by the Commonwealth Project, an organization dedicated to advancing medical cannabis access. Citing a PricewaterhouseCoopers (PwC) report, the group estimates that fully integrating cannabis into the U.S. health care system could save nearly $64 billion annually.

The video emphasizes the importance of the body’s endocannabinoid system, which regulates vital functions such as mood, appetite, memory, pain response, and homeostasis. According to the Commonwealth Project, as seniors age, this system weakens, contributing to chronic ailments. CBD, they argue, can restore balance and improve quality of life.

The narrator in the video highlights that nearly 20% of seniors already use CBD for conditions such as arthritis, Alzheimer’s disease, cancer symptoms, insomnia, and general pain management.

Trump’s Role in Cannabis Reform and the Historical Significance of the 2018 Farm Bill

Trump’s engagement in this issue is not entirely new. During his first term, he signed the 2018 Farm Bill, which legalized hemp cultivation across the United States and opened the door for widespread availability of CBD products.

Despite legalization, the U.S. Food and Drug Administration (FDA) has not created a comprehensive regulatory framework for CBD. As a result, seniors often face confusion, limited medical guidance, and inconsistent product quality. Trump’s latest endorsement could place pressure on federal agencies to act.

A Renewed Spotlight on the Cannabis Rescheduling Debate in Washington

The video’s release comes at a time of heightened discussion around cannabis rescheduling. The Biden administration began the process of moving cannabis from a Schedule I to a Schedule III substance, but the effort stalled earlier in 2025 after an administrative law judge retired before hearings could conclude.

If cannabis were moved to Schedule III, it would officially be recognized for its medicinal value, opening doors to research, physician guidance, and potentially broader insurance coverage. Trump has signaled that his administration will revisit the proposal within “the next few weeks,” leaving open the possibility of major reform during his current term.

Understanding the Endocannabinoid System and Its Role in Senior Health

The Commonwealth Project’s video explains that the endocannabinoid system (ECS) functions as a conductor in the body, coordinating interactions between major systems like the digestive, cardiovascular, respiratory, and nervous systems.

As people age, a weakening ECS can result in chronic pain, inflammation, cognitive decline, and sleep disorders. Hemp-derived CBD, according to the video, supports and strengthens the ECS, potentially reducing the need for addictive prescription medications.

While lifestyle adjustments such as exercise, diet, and stress management can aid ECS function, the group emphasizes CBD as a faster, more effective solution.

Growing Senior Interest in CBD and Cannabis-Based Health Care Solutions

The increasing popularity of CBD among seniors reflects shifting cultural attitudes toward cannabis. Surveys indicate that older adults are among the fastest-growing demographic groups turning to CBD for health concerns.

According to the Commonwealth Project, many seniors have already embraced CBD for:

• Arthritis and joint pain
• Sleep disorders and insomnia
• Cancer-related side effects
• Alzheimer’s and cognitive decline
• General stress and anxiety

For seniors, CBD is seen as a safer alternative to opioids and other prescription drugs with high risk of dependency.

Trump’s Political Messaging and the Push for a Legacy in Senior Health Care

The video frames Trump’s support for CBD as an opportunity to “revolutionize senior health care” and cement a presidential legacy. The narrator claims that Trump could lead “the most important senior health initiative of the century” by backing CBD integration into Medicare and expanding education for doctors about the endocannabinoid system.

Trump himself has acknowledged hearing “great things” about medical cannabis, particularly for pain management. His recent public embrace of CBD suggests that cannabis reform could become a central issue in his health care agenda.

Federal Agencies Face Pressure to Address CBD Regulation and Rescheduling

Despite CBD’s widespread use, regulatory uncertainty remains a significant barrier. The FDA has yet to issue comprehensive guidelines for hemp-derived CBD products, creating a patchwork marketplace where quality, dosage, and safety vary widely.

Without proper regulation, doctors often hesitate to recommend CBD, leaving seniors without the medical guidance they need. Advocates argue that Medicare coverage and physician education would normalize CBD use, improve safety, and expand access.

The Path Forward: Medicare, Rescheduling, and the Role of Trump’s Administration

If Trump’s administration moves forward with CBD coverage under Medicare, it would represent a groundbreaking shift in federal health care policy. Such a decision could reduce health care costs, improve outcomes for millions of seniors, and set the stage for broader cannabis integration.

Additionally, the pending cannabis rescheduling process remains critical. By moving cannabis to Schedule III, the federal government would officially recognize its medical potential and allow for expanded clinical research.

Trump’s Endorsement Signals a New Era in Cannabis and Senior Health Care

President Donald Trump’s decision to share the Commonwealth Project’s video highlights a growing recognition of CBD’s role in senior health care. While the move stops short of full cannabis rescheduling, it reflects a meaningful step toward normalizing CBD use, expanding Medicare coverage, and reshaping the conversation on senior wellness.

For seniors seeking alternatives to addictive pharmaceuticals, CBD could provide relief, longevity, and a better quality of life. For Trump, this initiative could become a defining moment in health care reform and his presidential legacy.

As the nation awaits the administration’s next steps, the future of medical cannabis and the health of millions of seniors hangs in the balance.

OG source Download Article